By Memorial Sloan-Kettering | Monday, July 2, 2012
Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.”
By Memorial Sloan-Kettering | Monday, June 25, 2012
Dr. Morrow, Chief of Memorial Sloan-Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
By Eva Kiesler, PhD, Science Writer/Editor | Monday, June 18, 2012
Rhonda D’Agostino cares for people with life-threatening complications due to cancer or its treatment – and helped pioneer a new ICU model that trains nurse practitioners and physician assistants to deliver the highest standard of care.
By Memorial Sloan-Kettering | Friday, June 15, 2012
Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.
In the News
By Media Staff | Tuesday, June 12, 2012
The magazine’s 15th annual issue recognizes more cancer physicians from Memorial Sloan-Kettering than any other hospital.
By Memorial Sloan-Kettering | Thursday, June 7, 2012
Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan-Kettering and the long-term relationships he maintains with his patients.
By Memorial Sloan-Kettering | Wednesday, June 6, 2012
In our recently updated guides to non-small cell and small-cell lung cancers, you can learn about diagnosis, treatment, follow-up care, lung cancer experts, and clinical trials at Memorial Sloan-Kettering.
By Memorial Sloan-Kettering | Tuesday, June 5, 2012
Memorial Sloan-Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
By Memorial Sloan-Kettering | Friday, June 1, 2012
Memorial Sloan-Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.
By Memorial Sloan-Kettering | Tuesday, May 29, 2012
Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.
By Allyson Collins, MS, Science Writer/Editor | Monday, May 21, 2012
In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan-Kettering | Monday, May 14, 2012
Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.